###begin article-title 0
The Fatty Acid Receptor GPR40 Plays a Role in Insulin Secretion In Vivo After High-Fat Feeding
###end article-title 0
###begin p 1
###xml 39 67 39 67 <email xmlns:xlink="http://www.w3.org/1999/xlink">vincent.poitout@umontreal.ca</email>
Corresponding author: Vincent Poitout, vincent.poitout@umontreal.ca
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-The G-protein-coupled receptor GPR40 is expressed in pancreatic beta-cells and is activated by long-chain fatty acids. Gene deletion studies have shown that GPR40 mediates, at least in part, fatty acid-amplification of glucose-induced insulin secretion (GSIS) but is not implicated in GSIS itself. However, the role of GPR40 in the long-term effects of fatty acids on insulin secretion remains controversial. This study aimed to test the hypothesis that GPR40 plays a role in insulin secretion after high-fat feeding.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-GPR40 knockout (KO) mice on a C57BL/6 background and their wild-type (WT) littermates were fed a high-fat diet (HFD) for 11 weeks. Glucose tolerance, insulin tolerance, and insulin secretion in response to glucose and Intralipid were assessed during the course of the diet period.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
RESULTS-GPR40 KO mice had fasting hyperglycemia. They became as obese, glucose intolerant, and insulin resistant as their WT littermates given HFD and developed a similar degree of liver steatosis. Their fasting blood glucose levels increased earlier than those of control mice during the course of the HFD. The remarkable increase in insulin secretory responses to intravenous glucose and Intralipid seen in WT mice after HFD was of much lower magnitude in GPR40 KO mice.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-GPR40 plays a role not only in fatty acid modulation of insulin secretion, but also in GSIS after high-fat feeding. These observations raise doubts on the validity of a therapeutic approach based on GPR40 antagonism for the treatment of type 2 diabetes.
###end p 6
###begin p 7
Published ahead of print at  on 16 June 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 357 358 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 359 360 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 514 515 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 516 517 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 518 519 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 550 551 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 582 583 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 617 619 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 620 622 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 691 693 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 707 709 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1131 1133 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 610 615 <span type="species:ncbi:10090">mouse</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
Fatty acids do not initiate insulin release in the absence of glucose, but they potentiate glucose-induced insulin secretion (GSIS) upon acute exposure. Their mechanisms of action are, however, incompletely understood. The discovery of GPR40 as a G-protein-coupled receptor highly expressed in pancreatic beta-cells and activated by long-chain fatty acids (1-4) has enabled the identification of a novel mechanism of action of fatty acids on insulin secretion. Loss of function of GPR40 via small interfering RNA (2,5-7), antisense oligonucleotides (8), pharmacological inhibitors (9), or gene deletion in the mouse (10,11) partially suppresses fatty acid potentiation of GSIS in vitro. We (10) and others (11) have shown that whole-body GPR40 knockout (KO) mice have normal glucose tolerance and unaltered insulin secretion in response to glucose in vivo and in vitro, but that isolated islets from these mice secrete less insulin in response to fatty acids. Furthermore, insulin secretion induced by Intralipid in vivo is reduced in GPR40 KO mice, demonstrating a physiological role for GPR40 in fatty acid-potentiation of GSIS (10).
###end p 9
###begin p 10
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 328 330 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 331 333 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 354 356 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 555 557 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 600 602 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 623 625 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
GPR40 has received considerable attention as a potential therapeutic target in type 2 diabetes (12-15). Surprisingly, whether an agonist or antagonist should be developed as a therapeutic agent remains debated (13,15). This uncertainty stems, in part, from conflicting reports regarding the role of GPR40 in beta-cell function (10,11). Steneberg et al. (11) found that islets isolated from GPR40 KO mice were protected from the inhibitory effects of prolonged fatty acid exposure on GSIS, in contrast to our findings in a different line of GPR40 KO mice (10) and a recent study using GPR40 agonists (16). Steneberg et al. (11) further showed that GPR40 KO mice were protected from high-fat diet (HFD)-induced insulin resistance, glucose intolerance, and hepatic steatosis. Given these discrepancies and the importance of determining whether an agonist or antagonist approach should be pursued for drug development, the present study was designed to test the hypothesis that GPR40 contributes to the enhancement of insulin secretion after HFD. Specifically, we sought to examine whether GPR40 KO mice are more susceptible to HFD-induced hyperglycemia and, if so, whether this is due to changes in insulin secretion in vivo or associated with changes in the expression of genes controlling fatty acid metabolism in islets.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin p 12
Reagents were from the following sources: 50% dextrose was from McKesson Canada (Montreal, Canada), 0.9% saline was from Baxter (Mississauga, Canada), and Intralipid was from Fresenius Kabi (Uppsala, Sweden). All other reagents were from Sigma (St. Louis, MO) unless otherwise noted.
###end p 12
###begin p 13
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">Mice</span>
GPR40 KO mice were generated as described (10) and backcrossed to the C57BL/6 strain for more than seven generations at Amgen (San Francisco, CA). Animals were housed under controlled temperature conditions (21degreesC) and a 12-h light/dark cycle with free access to food and water. At 7 weeks of age, male GPR40 KO and wild-type (WT) littermates were fed either high-fat (60% fat, 16% protein, and 24% carbohydrate on a caloric basis [#F3282; Bioserv Diets, Frenchtown, NJ]) or regular (23% fat, 17% protein, and 60% carbohydrates on a caloric basis [#2018; Harlan Teklad, Madison, WI]) diet. Mice were housed individually, and body weight and food intake were determined weekly. All procedures using animals were approved by the institutional committee for the protection of animals at the Centre Hospitalier de l'Universite de Montreal.
###end p 13
###begin title 14
Assessment of glucose homeostasis and insulin secretion.
###end title 14
###begin p 15
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 575 577 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 265 270 <span type="species:ncbi:9606">human</span>
Fasting blood glucose was measured weekly. Oral glucose tolerance was assessed in overnight-fasted animals after administration of 1 g/kg glucose by gavage (10). Insulin tolerance was measured in 5-h fasted animals after intraperitonial administration of 1 unit/kg human insulin (10). For measurements of insulin secretion in vivo, a catheter was inserted into the right jugular vein under general anesthesia. Insulin secretion in response to intravenous glucose (0.5 g/kg) or Intralipid (100 mul of a 20% solution preceded by 30 units of heparin) was measured as described (10).
###end p 15
###begin title 16
Tissue harvesting and histology.
###end title 16
###begin p 17
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed after 12 weeks of diet, and islets were isolated as described (10). Livers were snap-frozen in liquid nitrogen, embedded in OCT, prefrozen in anhydrous ethyl alcohol (100% ethanol), and stained with Oil Red O.
###end p 17
###begin title 18
Gene expression studies.
###end title 18
###begin p 19
###xml 144 146 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
Total RNA was extracted from approximately150 islets, and RT-PCR was carried out using the QuantiTect SYBR Green PCR kit (Qiagen) as described (17). Results are expressed as the ratio of target mRNA to beta-actin mRNA and normalized to the levels in islets from regular diet-fed WT mice, arbitrarily set as 1.
###end p 19
###begin title 20
Analytical measurements.
###end title 20
###begin p 21
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
Plasma glucose and fatty acid levels were measured enzymatically (Wako Chemicals, Neuss, Germany). Plasma insulin was measured using a mouse ELISA kit (Alpco Diagnostics, Salem, NH).
###end p 21
###begin title 22
Expression of data and statistics.
###end title 22
###begin p 23
###xml 145 146 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 171 172 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 211 218 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 223 229 221 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
Data are expressed as means +/- SE. Intergroup comparisons were performed by ANOVA with post hoc adjustments for 2-by-2 comparisons or Student's t test where appropriate. P < 0.05 was considered significant. In Table 1 and Fig. 3, glucose clearance and insulin secretion are expressed as the area under the curve, calculated above basal values, and expressed as arbitrary units.
###end p 23
###begin title 24
RESULTS AND DISCUSSION
###end title 24
###begin title 25
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Metabolic characteristics of GPR40 KO mice on a C57BL/6 background.
###end title 25
###begin p 26
###xml 143 144 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 160 161 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 241 242 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 262 263 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 278 279 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 272 279 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 835 837 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Seven-week-old GPR40 KO mice on a C57BL/6 background had body weight similar to that of their WT littermates (22.5 +/- 0.9 vs. 21.6 +/- 0.9 g; n = 10 for each; P = NS) but showed fasting hyperglycemia (135.8 +/- 5.3 vs. 115.4 +/- 4.1 mg/dl; n = 19-22 per group; P < 0.05; Fig. 1A). Glucose and insulin tolerance were similar in GPR40 KO and WT mice at 7 weeks of age (supplementary Fig. S1, available in an online appendix at ). Thus, on a pure C57BL/6 background, deletion of GPR40 leads to fasting hyperglycemia despite normal glucose and insulin tolerance, suggesting that GPR40 contributes to the maintenance of blood glucose levels during fasting. In the fasting state, circulating levels of fatty acids increase and the beta-cell uses fatty acids as its main energy source, with a corresponding increase in fatty acid oxidation (18). Our results therefore suggest that GPR40-mediated fatty acid signaling contributes to the maintenance of basal insulin secretion-and thereby normoglycemia-during fasting.
###end p 26
###begin title 27
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Effects of HFD on glucose and insulin tolerance in GPR40 KO mice.
###end title 27
###begin p 28
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 319 320 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 313 320 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 488 489 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 508 509 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 632 633 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 653 654 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 842 843 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 836 843 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 848 855 840 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1031 1032 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1025 1032 1017 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1091 1092 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1180 1181 1172 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1174 1181 1166 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1828 1830 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1955 1957 1947 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1995 1997 1987 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
###xml 1882 1886 <span type="species:ncbi:10090">mice</span>
###xml 1964 1968 <span type="species:ncbi:10090">mice</span>
Body weight, fat pad weight (white and brown adipose tissue), and food intake increased to similar levels in GPR40 KO and WT mice under HFD (Table 1). As expected, WT mice developed fasting hyperglycemia after 8 weeks of HFD. Fasting blood glucose increased earlier in GPR40 KO mice during the course of the HFD (Fig. 1B). Thus, after 3 weeks on diet, blood glucose levels of the KO mice on HFD were significantly higher than those on regular diet (123.8 +/- 5.2 vs. 101.9 +/- 5.8 mg/dl; n = 8-11 per group; P < 0.006), whereas WT mice on HFD and regular diet had similar blood glucose values (102.5 +/- 3.5 vs. 93.3 +/- 1.7 mg/dl, n = 10-11 per group; P > 0.08). Both GPR40 KO and WT animals were hyperglycemic after 8 weeks of HFD. Oral and intravenous glucose tolerance were impaired to a similar extent in WT and KO mice after HFD (Fig. 2A and Table 1) compared with mice on regular diet (supplementary Fig. S2A). Similarly, the glucose-lowering effect of insulin was reduced to the same extent in both genotypes on HFD (Fig. 2B) compared with mice on regular diet (supplementary Fig. S2B). Liver steatosis developed in all animals examined of both genotypes under HFD (Fig. 2C). Thus, GPR40 KO mice on a C57BL/6 background have fasting hyperglycemia that is further aggravated during HFD. Furthermore, HFD in both GPR40 KO mice and their WT littermates is associated with insulin resistance and glucose intolerance. Although we have not performed euglycemic-hyperinsulinemic clamps to directly measure insulin sensitivity, the observed decrease in the glucose-lowering effects of insulin, combined with the presence of liver steatosis, indicate that GPR40 KO mice were not protected from the development of insulin resistance during HFD. We suspect that the discrepancies between our results and those of Steneberg et al. (11) might be related to the genetic background of the mice, an important determinant of susceptibility to glucose intolerance (19). The mice used by Steneberg et al. (11) were of a mixed background as opposed to the C57BL/6 background used in the present study.
###end p 28
###begin title 29
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Effects of HFD on insulin secretion in GPR40 KO mice.
###end title 29
###begin p 30
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 304 317 304 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic>, <italic>C</italic>, <italic>D</italic></xref>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 440 453 440 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic> and <italic>D</italic></xref>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 518 531 518 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic> and <italic>D</italic></xref>
###xml 773 775 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1066 1068 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1069 1071 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
To examine whether GPR40 plays a role in insulin secretion after HFD, we measured insulin release in response to glucose and Intralipid after 10 and 11 weeks, respectively, of HFD or regular diet. Insulin secretion in response to intravenous glucose was similar in regular diet-fed GPR40 KO and WT mice (Fig. 3A, C, D). After administration of HFD, the second-phase insulin secretion to intravenous glucose was greatly enhanced in WT mice (Fig. 3B and D), and this increase was significantly blunted in GPR40 KO mice (Fig. 3B and D). These results suggest that GPR40 becomes rate-limiting for GSIS after HFD. These findings are consistent with the observation that enhancement of intracellular lipid signaling plays a role in beta-cell compensation for insulin resistance (20). Interestingly, the marked differences in GSIS between GPR40 KO and WT mice after HFD were not accompanied by changes in glucose clearance, which is in keeping with the notion that glucose clearance after an intravenous load in mice is mostly determined by insulin-independent mechanisms (21,22).
###end p 30
###begin p 31
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 12 25 12 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic> and <italic>G</italic></xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 335 336 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 344 345 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 497 498 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 499 500 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 491 500 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>F</italic>&#8211;<italic>H</italic></xref>
###xml 641 642 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 643 644 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 635 644 631 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>F</italic>&#8211;<italic>H</italic></xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
As shown in Fig. 3E and G, GPR40 KO mice on a C57BL/6 background have reduced insulin secretion in response to Intralipid, as previously shown in mice on a mixed background (23). Thus, first-phase insulin secretion was lower in GPR40 KO mice in response to Intralipid compared with WT littermates (6.72 +/- 1.59 vs. 11.10 +/- 1.47 AU; n = 6-7; P < 0.05). After 11 weeks on HFD, WT mice had a markedly increased response to intravenous Intralipid compared with that of regular diet-fed mice (Fig. 3F-H). In contrast, the increase in first-phase insulin release in response to Intralipid after HFD was markedly reduced in GPR40 KO mice (Fig. 3F-H). These findings show that GPR40 not only plays a role in insulin secretion in response to fatty acids under basal conditions but is essential for the beta-cell to mount a compensatory increase in insulin secretion in response to both glucose and fatty acids in the face of HFD-induced insulin resistance.
###end p 31
###begin title 32
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Effects of HFD on gene expression in GPR40 KO mice.
###end title 32
###begin p 33
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 985 992 985 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 1561 1565 <span type="species:ncbi:10090">mice</span>
To gain insight into the molecular basis for the role of GPR40 in insulin secretion, mRNA levels of genes involved in fatty acid transport and metabolism were measured in islets from GPR40 KO and WT mice after HFD or regular diet (Table 1). GPR120 is another receptor for long-chain fatty acids expressed in enteroendocrine cells (23). We found GPR120 mRNA to be expressed in isolated mouse islets, although its expression did not increase in compensation for the absence of GPR40 in GPR40 KO islets (Table 1). CD36 is a fatty acid transport protein that plays an important role in fatty acid uptake and fatty acid potentiation of GSIS (24). Carnitine palmitoyl transferase-1 (CPT-1) catalyzes the rate-limiting step in fatty acid oxidation, i.e., transport of long-chain acyl-CoAs across the mitochondrial membrane (25). GPR40 KO mice on regular diet displayed an approximate five and sevenfold increase in islet CD36 and CPT-1 mRNA expression, respectively, compared with WT islets (Table 1), suggesting an attempt to compensate for the absence of GPR40 by enhancing fatty acid transport and intracellular metabolism. Although expression of neither CD36 nor CPT-1 was significantly affected by HFD in WT animals, in KO islets the increase in CD36 and CPT1 gene expression was markedly reduced by HFD. This suggests that enhanced expression of CD36 and CPT1 perhaps contributes to the maintenance of normal glucose tolerance despite the absence of GPR40 under basal conditions, but that the absence of such an increase under HFD results in an inability of the mice to sustain normal GSIS.
###end p 33
###begin p 34
###xml 9 13 <span type="species:ncbi:10090">mice</span>
GPR40 KO mice on a C57BL/6 background have fasting hyperglycemia and are not protected from HFD-induced insulin resistance, and GPR40 is implicated not only in insulin secretion in response to fatty acids but also in GSIS after HFD. These findings suggest that the mechanisms by which the beta-cell mounts a compensatory response to HFD-induced insulin resistance involve, at least in part, signaling through GPR40. As such, our results raise doubts on the validity of a therapeutic approach based on GPR40 antagonism for the treatment of type 2 diabetes.
###end p 34
###begin title 35
Supplementary Material
###end title 35
###begin title 36
Online-Only Appendix
###end title 36
###begin title 37
Revised Figure 2
###end title 37
###begin p 38
This work was supported by a grant from the National Institutes of Health (R21-DK070589). T.A. is the recipient of a postdoctoral fellowship from the Canadian Diabetes Association. V.P. holds the Canada Research Chair in Diabetes and Pancreatic beta-Cell Function.
###end p 38
###begin p 39
We thank Dr. Louis Gaboury, Institut de Recherche en Immunologie et en Cancerologie, Universite de Montreal, Montreal, Quebec, Canada, for liver histological examinations; Drs. Daniel C.-H. Lin and Helene Baribault (Amgen) for providing GPR40 KO breeders; Dr. Marc Prentki for critical reading of the manuscript; and Grace Fergusson and Melanie Ethier for technical help.
###end p 39
###begin title 40
REFERENCES
###end title 40
###begin p 41
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Fasting blood glucose levels of GPR40 KO and WT mice before (A) and during (B) feeding a high-fat (HF) or regular diet (RD). *P < 0.05.
###end p 41
###begin p 42
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
A: Glucose levels during oral glucose tolerance tests (OGTTs) after 8 weeks of HFD; n = 10-11 mice per group. B: Glucose levels during intraperitoneal insulin tolerance tests (IPITTs) after 9 weeks of HFD; n = 8-10 mice per group. C: Oil Red O staining of liver sections of KO and WT mice fed regular diet (RD) or HFD. Images are representative of 3-4 animals in each group. (Please see  for a high-quality digital representation of this figure.)
###end p 42
###begin p 43
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 298 299 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 304 305 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 392 393 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 403 404 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 407 408 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 413 414 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 471 472 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 494 495 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 590 591 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
A and B: Insulin levels in response to intravenous glucose after 10 weeks of regular diet (RD) (A) or HFD (B). C and D: Area under the curve (AUC) for insulin over the first 10 min (C) and from 10-60 min (D) following glucose injection. Values are expressed as means +/- SE of 8-10 mice per group. E and F: Insulin levels in response to intravenous Intralipid after 11 weeks of regular diet (E) or HFD (F). G and H: Area under the curve for insulin for the first 10 min (G) and from 10-60 min (H) following Intralipid injection. Values are expressed as means +/- SE of 6-8 mice per group. *P < 0.
###end p 43
###begin p 44
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Metabolic parameters of GPR40 knockout and wild-type mice fed regular diet or HFD and gene expression levels in islets
###end p 44
###begin p 45
###xml 23 24 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Data are means +/- SE. n = 9-12 animals per group. AUC, area under the curve; IVGTT, intravenous glucose tolerance test; ND, not determined; OGTT, oral glucose tolerance test; RD, regular diet.
###end p 45
###begin p 46
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. RD;
###end p 46
###begin p 47
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. WT.
###end p 47

